Essity B 293 (-3.8 SEK) on 31-Mar-2023 17:29
Select region

Global Site

USA USA Russia Russia Germany Germany Mexico Mexico Netherlands Netherlands France France Sweden Sweden Italy Italy Spain Spain

Did you mean

    Advanced search

    Quick results

    View all results

    These might help

    Corporate press releases

    Corporate News

    Investor Relations Calendar

    Essity logo
    Brands

    Company

    We are a leading global hygiene and health company

    Explore our Company

    Essity at a Glance
    Purpose and Vision Our Beliefs Our History
    Business Areas
    Health & Medical Consumer Goods Professional Hygiene Market and Trends E-Commerce
    Breaking Barriers to Well-being
    Stories Partnerships Insights Events Articles
    Strategy
    Our Business Model Our Strategic Priorities
    Organization and Management
    Board of Directors Executive Management Team
    Corporate Governance
    Articles of Association General Meeting Nomination Committee Auditors Board and Committee Work Remuneration to the Board of Directors Remuneration Policy Public Policies Sustainability Governance
    Essity in the World

    Brands

    Brands

    Sustainability

    We are committed to improving the well-being of people and planet

    Explore Sustainability

    Improving well-being for people and societies
    Hygiene and Health Diversity, Equity and Inclusion Business Ethics & Human Rights Occupational health and safety Product safety and transparency
    Reducing our environmental impact on the planet
    Forest & Fiber GHG Emissions Plastics & Packaging Waste and recycling Water use
    Sustainability reporting, governance and data
    Annual and Sustainability Report Sustainability Governance Ratings and Recognitions
    Role in Society
    Partnerships and Collaborations Essity in the Spotlight Ways of Working Trade Associations and Policy Organizations Public Policy Development Positions Advancing the Knowledge
    Contact Us

    Innovation

    Innovation is deeply embedded in our company’s strategy and business model

    Explore Innovations

    Products and Solutions
    Digitalization
    Essity Ventures
    Latest Innovations

    Careers

    We want to improve the lives of people every day

    Explore Careers

    Job Opportunities
    Work at Essity
    Commitment to Our Employees Diversity, Equity and Inclusion Learning and Development Why Choose Essity?
    Students and Graduates
    Graduates Students Internships Apprenticeships
    Life at Essity
    Women in Technology Career Stories
    Alumni Network
    Connect with Us
    Career Events Listen to us
    Total Rewards

    Investors

    Explore Investor

    Essity as an Investment
    Targets and Outcomes
    Essity Share
    Data per Share Ownership Dividend List of Analysts Trade Information Share Conversion Share Capital Development Indexes
    Financials
    Reports
    Interim Reports Annual Reports Prospectus
    Presentations and Webcasts
    Business Area Web Presentations
    Capital Markets Day 2021
    Investor Day 2019
    Debt Financing
    Debt Programmes Credit Rating Funding Sources Key Debt Ratios
    Essity Data
    Acquisitions and Divestments
    Investor Relations Calendar
    Investor Relations Contacts
    Subscribe

    Media

    Explore Press Center

    Press Releases
    News Features
    Images & Video
    Subscribe
    Media Contact
    Local Media Contacts
    Essity in Social Media
    Home
    Media
    Press releases
    2021
    Media
    Press Releases News Features Images & Video Subscribe Media Contact Essity in Social Media

    December 29, 2021

    Essity acquires advanced wound care company in US

    Hygiene and health company Essity has acquired the company Hydrofera. The company offers technology and products within advanced wound care. The purchase price amounts to USD 116m (approximately SEK 1.1bn) with a potential additional earnout amount of USD 15m (approximately SEK 137m) on a cash and debt free basis. The acquisition supports Essity’s strategic priority to grow through acquisitions in Medical Solutions.

    The US company Hydrofera was founded in 1996 and is a developer of Hydrofera Blue Antibacterial Wound Dressings, an advanced line of wound care products designed to shorten healing times, lower treatment costs, and deliver better patient outcomes. The company, which has about 90 employees, has its head office in Manchester, Connecticut and is present in more than 15 countries. 

    For the first nine months of 2021, Hydrofera reported net sales of USD 20.7m (SEK 176m) with an EBITDA of USD 5,9m (SEK 50m), an EBITA of USD 5,6m (SEK 48m), equivalent to an EBITA margin of 27.2%. Sales growth for the first nine months of 2021 amounted to 22%. In 2020, the company reported net sales of approximately USD 23.5m (SEK 216m), with an EBITDA of USD 4.6m (SEK 42m) and EBITA of USD 4.3m (SEK 39m), equivalent to an EBITA margin of 18.1%. Sales growth in 2020 amounted to 13%. The acquisition is expected to be accretive to Essity’s earnings per share in 2022.  

    “The acquisition of Hydrofera is yet another great strategic fit for Essity further strengthening our innovation capacity and expanding our offering within advanced wound care. The company has innovations that significantly accelerate healing and reduce the patient's discomfort,” says Ulrika Kolsrud, President Health and Medical Solutions at Essity. 

    Hydrofera has a direct sales force and maintains agreements and preferred provider status with the major national medical/surgical distributors and buying groups in the US and Canadian healthcare markets. Products are used across the entire care range such as hospitals, wound clinics, long term care facilities and homecare. The suite of products is designed to meet requirements for a wide variety of wound care needs. 

    Essity’s medical solutions business offers innovative and high-quality medical products in wound care, compression, and orthopedics with global brands such as Leukoplast, Cutimed, JOBST, Actimove and Delta-Cast. In acute and advanced wound care, Essity is the world’s fifth largest player. 

    NB: This information is such that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 14:00 CET on December 29, 2021. 

    Karl Stoltz, Media Relations Manager, +46 709 426 338

    Essity acquires advanced wound care company in US
    Back to press releases

    Share this

    Essity logo
    Company Careers Brands Breaking Barriers Contact Us
    Privacy Policy Cookies Terms and Conditions

    Tel +46 8-788 51 00

    © Essity Aktiebolag (publ). Box 200, SE-101 23, Stockholm, Sweden